Medical Device Company Pulmonx Files for IPO
February 28 2020 - 6:51PM
Dow Jones News
By Josh Beckerman
Pulmonx Corp., a medical device company that provides the Zephyr
valve system for severe emphysema, disclosed plans for an initial
public offering.
Pulmonx previously filed confidentially for an IPO. The Redwood
City, Calif., company is seeking a Nasdaq Global Market listing
under the symbol LUNG.
Boston Scientific Corp. owns 30% of Pulmonx. Last May, Pulmonx
closed $65 million of equity financing led by Ally Bridge
Group.
Pulmonx had 2019 revenue of $32.6 million, compared with $20
million in 2018.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
February 28, 2020 18:36 ET (23:36 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Apr 2023 to Apr 2024
